Crucell Receives US Patent Covering its STAR(TM) Technology

06-Apr-2005

Crucell N.V. announced that it has been granted a patent by the United States Patent and Trademark Office for its STAR(TM) technology.

The newly issued patent is the first and basic patent in a portfolio pertaining to the STAR(TM) technology developed by professor Arie Otte of Chromagenics B.V., a company acquired by Crucell in March 2004. The patent generally covers the identification and selection of so-called STAR(TM) sequences that find use in boosting the production of therapeutic proteins in cell-culture systems.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances